Monocyclic thiophenes as protein tyrosine phosphatase 1B inhibitors: capturing interactions with Asp48.

[1]  A. Moretto,et al.  Bicyclic and tricyclic thiophenes as protein tyrosine phosphatase 1B inhibitors. , 2006, Bioorganic & medicinal chemistry.

[2]  P. Hajduk,et al.  Isoxazole carboxylic acids as protein tyrosine phosphatase 1B (PTP1B) inhibitors. , 2004, Bioorganic & medicinal chemistry letters.

[3]  Wolfgang H. B. Sauer,et al.  Prospects for inhibitors of protein tyrosine phosphatase 1B as antidiabetic drugs. , 2004, Journal of medicinal chemistry.

[4]  Scott D. Taylor,et al.  Recent advances in protein tyrosine phosphatase 1B inhibitors , 2004, Expert opinion on investigational drugs.

[5]  C. Bayly,et al.  Structure based design of a series of potent and selective non peptidic PTP-1B inhibitors. , 2004, Bioorganic & medicinal chemistry letters.

[6]  E. Asante-Appiah,et al.  The development of potent non-peptidic PTP-1B inhibitors. , 2004, Bioorganic & medicinal chemistry letters.

[7]  Gang Liu,et al.  Selective protein tyrosine phosphatase 1B inhibitors: targeting the second phosphotyrosine binding site with non-carboxylic acid-containing ligands. , 2003, Journal of medicinal chemistry.

[8]  A. Fedorov,et al.  Crystal Structure of PTP1B Complexed with a Potent and Selective Bidentate Inhibitor* , 2003, The Journal of Biological Chemistry.

[9]  S. Larsen,et al.  Modification of the N-terminus of peptidomimetic protein tyrosine phosphatase 1B (PTP1B) inhibitors: identification of analogues with cellular activity. , 2003, Bioorganic & medicinal chemistry letters.

[10]  B. Kennedy,et al.  Protein tyrosine phosphatase 1B: a novel target for type 2 diabetes and obesity. , 2003, Current topics in medicinal chemistry.

[11]  J. Ermolieff,et al.  Protein tyrosine phosphatase 1B inhibitors for diabetes , 2002, Nature Reviews Drug Discovery.

[12]  M. J. Newman,et al.  Discovery and SAR of a novel selective and orally bioavailable nonpeptide classical competitive inhibitor class of protein-tyrosine phosphatase 1B. , 2002, Journal of medicinal chemistry.

[13]  J. Waring,et al.  PTP1B antisense oligonucleotide lowers PTP1B protein, normalizes blood glucose, and improves insulin sensitivity in diabetic mice , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[14]  J. Waring,et al.  Protein tyrosine phosphatase 1B reduction regulates adiposity and expression of genes involved in lipogenesis. , 2002, Diabetes.

[15]  J. Tobin,et al.  Recent advances in the development of small molecule inhibitors of PTP1B for the treatment of insulin resistance and type 2 diabetes. , 2002, Current opinion in drug discovery & development.

[16]  D. Lawrence,et al.  Acquisition of a Specific and Potent PTP1B Inhibitor from a Novel Combinatorial Library and Screening Procedure* , 2001, The Journal of Biological Chemistry.

[17]  C. Bayly,et al.  The YRD Motif Is a Major Determinant of Substrate and Inhibitor Specificity in T-cell Protein-tyrosine Phosphatase* , 2001, The Journal of Biological Chemistry.

[18]  Young-Bum Kim,et al.  Increased Energy Expenditure, Decreased Adiposity, and Tissue-Specific Insulin Sensitivity in Protein-Tyrosine Phosphatase 1B-Deficient Mice , 2000, Molecular and Cellular Biology.

[19]  B. Kennedy,et al.  Increased insulin sensitivity and obesity resistance in mice lacking the protein tyrosine phosphatase-1B gene. , 1999, Science.

[20]  O. Pedersen,et al.  Expression of protein‐tyrosine phosphatases in the major insulin target tissues , 1997, FEBS letters.

[21]  Gang Liu,et al.  Recent advances in protein-tyrosine-phosphatase 1B (PTP1B) inhibitors for the treatment of type 2 diabetes and obesity , 2004 .

[22]  R. Ulrich,et al.  Reduction of protein tyrosine phosphatase 1B increases insulin-dependent signaling in ob/ob mice. , 2003, Diabetes.